Search

everythinglearnresearchcommunity

for

Search:↓

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Neurosteroids show promise for treating epilepsy and more research is needed.

MorrF improves hair growth better than minoxidil alone.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Androgenic alopecia causes hair follicle degradation and skin restructuring, but some hair elements remain.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Patients with Complete Androgen Insensitivity Syndrome need psychological support and multidisciplinary care for complex treatment decisions.

Certain dietary supplements can improve hair density and are well-tolerated for treating androgenetic alopecia.

Improving blood flow and oxygen levels in middle age may help prevent age-related diseases.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Advancements in understanding, diagnosing, and managing congenital adrenal hyperplasia have improved treatment and long-term outcomes.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

New engineering methods show promise for regenerating hair follicles using stem cells and advanced technologies.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.